A Phase II Study Evaluating the Combination of Nivolumab (Nivo) or Ipilimumab (Ipi) with Azacitidine in Pts with Previously Treated or Untreated Myelodysplastic Syndromes (MDS)
Year: 2016
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Guillermo Garcia-Manero, Naval G. Daver, Guillermo Montalban-Bravo, Elias J. Jabbour, Courtney D. DiNardo, Steven M. Kornblau, Prithviraj Bose, Yesid Alvarado, Maro Ohanian, Gautam Borthakur, Jorge E. Cortes, Kiran Naqvi, Naveen Pemmaraju, Xuelin Huang, Graciela M. Nogueras-Gonzalez, Carlos E Bueso-Ramos, Yvonne Gasior, Virginia R Bayer, Sherry Pierce, Hui Yang, Simona Colla, Hagop M. Kantarjian
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2604291631